One recent study suggests that the highly-expressed BCAT1 in blast crisis chronic myeloid leukemia (BC-CML) re-amidate BCKA into BCAA, thus promoting the mTOR signaling pathway and the progress of BC-CML (34). This evidence concerns the gene ARID4B and breast cancer.